Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories (NY: BIO )

496.07 +0.91 (+0.18%)
Official Closing Price Updated: 4:10 PM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 126,518
Open 493.26
Bid (Size) 437.69 (1)
Ask (Size) 750.00 (1)
Prev. Close 495.16
Today's Range 485.08 - 499.06
52wk Range 462.61 - 832.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bio-Rad Publishes Corporate Sustainability Report
From Bio-Rad Laboratories, Inc.
Via Business Wire
7 Profitable Places to Hide Your Money During a Bear Market
With an imminent bear market on the horizon, investors are searching for alternative investment paths for diversification. 
Via InvestorPlace

Performance

YTD
-32.55%
-32.55%
1 Month
-7.76%
-7.76%
3 Month
-14.76%
-14.76%
6 Month
-33.66%
-33.66%
1 Year
-22.93%
-22.93%

More News

Read More
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Earnings Scheduled For February 10, 2022
Via Benzinga
Recap: Bio-Rad Laboratories Q1 Earnings
Via Benzinga
Bio-Rad Reports First-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Will Investment Gains For Google Parent Reverse In Upcoming Earnings Report?
Via Investor's Business Daily
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead
Via InvestorPlace
Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day
From Bio-Rad Laboratories, Inc.
Via Business Wire
7 Stocks To Buy at the Bottom After the Market Rout
Via InvestorPlace
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
Via Benzinga
Recap: Bio-Rad Laboratories Q4 Earnings
Via Benzinga
Bio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Via Benzinga
Bio-Rad Laboratories's Earnings: A Preview
Via Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Via Benzinga
Bio-Rad to Host Investor Day on February 25
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11
From Bio-Rad Laboratories, Inc.
Via Business Wire
Free COVID Tests: What Stocks Will Benefit?
Via Talk Markets
Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President
From Bio-Rad Laboratories, Inc.
Via Business Wire
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.